연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
2905. Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease.
Park JC, Noh J, Jang S, Kim KH, Choi H, Lee D, Kim J, Chung J, Lee DY, Lee Y, Lee H, Yoo DK, Lee AC, Byun MS, Yi D, Han SH, Kwon S, Mook-Jung I.
Cell Rep. 2022 Sep 20;40(12)
Link
2904. Standard versus longer interval of radical resection after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A 20-year single-center experience & propensity-score matching
Saule Khamzina 1 2, Jongoh Lee 3, Seung-Bum Ryoo 3 4 5, Min Jung Kim 3 4 5, Ji Won Park 3 4 5, Hyun-Cheol Kang 6, Eui Kyu Chie 6, Dae-Won Lee 7, Sae-Won Han 7, Tae-You Kim 7, Seung-Yong Jeong 3 4 5, Kyu Joo Park 3 4
J Surg Oncol. 2023 Jan;127(1):119-131.
Link
2903. Mice transgenic for human CTLA4-CD28 fusion gene show proliferation and transformation of ATLL-like and AITL-like T cells
Gyu Jin Lee 1 2, Yukyung Jun 3, Yoon Kyung Jeon 4 5, Daekee Lee 1, Sanghyuk Lee 1 2 3, Jaesang Kim 1 2 3
Oncoimmunology. 2022 Jan 4;11(1):2015170.
Link
2902. Interlaboratory Comparison Study (Ring Test) of Next-Generation Sequencing‒Based NTRK Fusion Detection in South Korea
Seung Eun Lee 1, Mi-Sook Lee 2, Yoon Kyung Jeon 3, Hyo Sup Shim 4, Jun Kang 5, Jihun Kim 6, Yoon-La Choi 2 7
Cancer Res Treat. 2022 Feb 10.
Link
2901. Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma
Mi-Sook Lee 1 2, Sungbin An 1 2, Ji-Young Song 2, Minjung Sung 2, Kyungsoo Jung 1 2, Eun Sol Chang 1 2, Juyoung Choi 2 3, Doo-Yi Oh 4, Yoon Kyung Jeon 5 6, Hobin Yang 7, Chaithanya Lakshmi 8, Sehhoon Park 9, Joungho Han 10, Se-Hoon Lee 1 9, Yoon-La Choi 1 2 10
Cancer Res Treat. 2022 Oct 14.
Link
2900. Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
Sara A Hurvitz 1, Roberto Hegg 2, Wei-Pang Chung 3, Seock-Ah Im 4, William Jacot 5, Vinod Ganju 6, Joanne Wing Yan Chiu 7, Binghe Xu 8, Erika Hamilton 9, Srinivasan Madhusudan 10, Hiroji Iwata 11, Sevilay Altintas 12, Jan-Willem Henning 13, Giuseppe Curigliano 14, José Manuel Perez-Garcia 15, Sung-Bae Kim 16, Vanessa Petry 17, Chiun-Sheng Huang 18, Wei Li 19, Jean-Sebastien Frenel 20, Silvia Antolin 21, Winnie Yeo 22, Giampaolo Bianchini 23, Sherene Loi 24, Junji Tsurutani 25, Anton Egorov 26, Y
Lancet. 2023 Jan 14;401(10371):105-117.
Link
2899. Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3
Hope S Rugo 1, Seock-Ah Im 2, Anil A Joy 3, Yaroslav Shparyk 4, Janice M Walshe 5, Bethany Sleckman 6, Sherene Loi 7, Kathy Puyana Theall 8, Sindy Kim 9, Xin Huang 10, Eustratios Bananis 11, Reshma Mahtani 12, Richard S Finn 13, Véronique Diéras 14
Breast. 2022 Dec;66:324-331.
Link
2898. The Effect of Temperament on the Association Between Pre-treatment Anxiety and Chemotherapy-Related Symptoms in Patients With Breast Cancer
Jung-In Choi 1 2, Sanghyup Jung 3 4, Gyu Han Oh 5, Kyung-Lak Son 6, Kwang-Min Lee 7, Dooyoung Jung 8, Tae-Yong Kim 9 10, Seock-Ah Im 9 10 11, Kyung-Hun Lee 9 10, Min-Sup Shin 4, Bong-Jin Hahm 2 4, Chan-Woo Yeom 12
Psychiatry Investig. 2022 Nov;19(11):949-957.
Link
2897. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
C E Geyer Jr 1, J E Garber 2, R D Gelber 3, G Yothers 4, M Taboada 5, L Ross 6, P Rastogi 1, K Cui 7, A Arahmani 8, G Aktan 9, A C Armstrong 10, M Arnedos 11, J Balmaña 12, J Bergh 13, J Bliss 14, S Delaloge 15, S M Domchek 16, A Eisen 17, F Elsafy 5, L E Fein 18, A Fielding 7, J M Ford 19, S Friedman 20, K A Gelmon 21, L Gianni 22, M Gnant 23, S J Hollingsworth 24, S-A Im 25, A Jager 26, Ó Þ Jóhannsson 27, S R Lakhani 28, W Janni 29, B Linderholm 30, T-W Liu 31, N Loman 32, L Korde 33, S Loibl
Ann Oncol. 2022 Dec;33(12):1250-1268.
Link
2896. Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
Hope S Rugo 1, Seock-Ah Im 2, Fatima Cardoso 3, Javier Cortes 4 5, Giuseppe Curigliano 6, Antonino Musolino 7 8 9, Mark D Pegram 10, Thomas Bachelot 11, Gail S Wright 12, Cristina Saura 13, Santiago Escrivá-de-Romaní 13, Michelino De Laurentiis 14, Gary N Schwartz 15, Timothy J Pluard 16, Francesco Ricci 17, William R Gwin 3rd 18, Christelle Levy 19, Ursa Brown-Glaberman 20, Jean-Marc Ferrero 21, Maaike de Boer 22, Sung-Bae Kim 23, Katarína Petráková 24, Denise A Yardley 25, Orit Freedman 26, Er
J Clin Oncol. 2023 Jan 10;41(2):198-205. doi: 10.1200/JCO.21.02937. Epub 2022 Nov 4.
Link